| VRC01 / Acuitas Therap |
NCT02140255: Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission |
|
|
| Recruiting | 1/2 | 1120 | US, RoW | Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Nevirapine (NVP), Lopinavir/Ritonavir (LPV/r), Raltegravir (RAL), VRC01, DTG, VRC07-523LS | National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH) | HIV Infection | 01/28 | 12/31 | | |
NCT03729752: PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01) |
|
|
| Recruiting | 1 | 30 | US | [89]Zr-DFO-VRC-HIVMAB060-00-AB, [89]Zr-DFO-VRC01 | University of California, San Francisco, amfAR, The Foundation for AIDS Research | HIV-1-infection | 10/24 | 01/25 | | |
NCT06006546: The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies |
|
|
| Recruiting | 1 | 40 | US | 426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum | National Institute of Allergy and Infectious Diseases (NIAID) | Chronic HIV Infection | 12/25 | 12/25 | | |
NCT04860323: Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study |
|
|
| Active, not recruiting | N/A | 13 | RoW | Analytical Treatment Interruption | HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), HIV Prevention Trials Network, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | HIV Infection | 02/25 | 02/25 | | |
NCT04801758: Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study |
|
|
| Completed | N/A | 18 | RoW | Analytical Treatment Interruption | HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), HIV Prevention Trials Network, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | HIV Infection | 07/24 | 07/24 | | |
| FB121 (ibalizumab biosimilar) / Microbio |
| No trials found |
| VRC01LS / National Institutes of Health, Xencor |
| No trials found |
| IT1208 / IDAC Theranostics, Ono Pharma |
| No trials found |
| combinectin (GSK3732394) / ViiV Healthcare, GSK |
| No trials found |
| CD4 CAR NK cells / iCell Gene Therap |
| No trials found |
| clenoliximab (IDEC-151) / Biogen |
| No trials found |
